global point of care
Der i-STAT CK-MB Test ist ein In-vitro- Diagnosetest zur quantitativen Messung der Masse von Creatinkinase-MB in Vollblut- oder Plasmaproben. Die CK-MB Messung kann als Hilfsmittel bei der Diagnose und Behandlung eines Myokardinfarkts (MI) eingesetzt werden.
A leader in rapid point-of-care diagnostics
©2023 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.